{"timestamp": 1771609045.1509933, "value": {"ticker": "SLS", "company_name": "SELLAS Life Sciences Group, Inc.", "short_name": "SELLAS Life Sciences Group, Inc", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 701544960, "float_shares": 141792702, "shares_outstanding": 170282026, "short_ratio": 3.28, "short_percent_of_float": 0.2442, "shares_short": 41330037, "shares_short_prior": 49429420, "insider_percent_held": 0.0064700004, "institution_percent_held": 0.20834999, "total_cash": 44320000, "total_debt": 599000, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 1.313, "current_ratio": 8.279, "book_value": 0.365, "price_to_book": 11.287397, "operating_cashflow": -30621000, "free_cashflow": -22079124, "price": 4.1199, "52w_high": 5.18, "52w_low": 0.95, "avg_volume": 8210288, "avg_volume_10d": 4637130, "full_time_employees": 15, "audit_risk": 7, "overall_risk": 6}}